What service do you need? Contact Request

NCT06873789

A Study to Evaluate INCB177054 in Participants With Select Advanced or Metastatic Solid Tumors

← Hub

Registry fields

Overall status: TERMINATED
Conditions: Solid Tumors, Advanced Solid Tumors, Metastatic Solid Tumors
Study type: INTERVENTIONAL
Phase: PHASE1, PHASE2
Primary purpose: TREATMENT
Intervention type: DRUG
Interventions: INCB177054, Retifanlimab
Lead sponsor: Incyte Corporation (INDUSTRY)

Cached at: 2026-09-03 04:59:37

View on ClinicalTrials.gov

Brief summary

This study will be conducted to evaluate INCB177054 given as monotherapy or in combination with retifanlimab in participants with select advanced or metastatic solid Tumors.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report